chr1-196779264-A-G
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BP4
The NM_021023.6(CFHR3):āc.161A>Gā(p.Tyr54Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000393 in 1,526,092 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_021023.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CFHR3 | NM_021023.6 | c.161A>G | p.Tyr54Cys | missense_variant | 2/6 | ENST00000367425.9 | |
CFHR3 | NM_001166624.2 | c.161A>G | p.Tyr54Cys | missense_variant | 2/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CFHR3 | ENST00000367425.9 | c.161A>G | p.Tyr54Cys | missense_variant | 2/6 | 1 | NM_021023.6 | P1 | |
CFHR3 | ENST00000471440.6 | c.161A>G | p.Tyr54Cys | missense_variant | 2/5 | 1 | |||
CFHR3 | ENST00000391985.7 | c.161A>G | p.Tyr54Cys | missense_variant | 2/5 | 2 | |||
CFHR3 | ENST00000367427.7 | c.161A>G | p.Tyr54Cys | missense_variant, NMD_transcript_variant | 2/7 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000146 AC: 2AN: 136984Hom.: 1 Cov.: 24
GnomAD4 exome AF: 0.00000288 AC: 4AN: 1389108Hom.: 1 Cov.: 30 AF XY: 0.00000145 AC XY: 1AN XY: 690128
GnomAD4 genome AF: 0.0000146 AC: 2AN: 136984Hom.: 1 Cov.: 24 AF XY: 0.0000300 AC XY: 2AN XY: 66662
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 14, 2023 | The c.161A>G (p.Y54C) alteration is located in exon 2 (coding exon 2) of the CFHR3 gene. This alteration results from a A to G substitution at nucleotide position 161, causing the tyrosine (Y) at amino acid position 54 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at